CMR Molecular Imaging

About CMR Molecular Imaging

A Other / Uncategorized player with a presence on the SNMMI floor; commercial activity worth a closer look.

Longer summary placeholder. Replace once Bracken finalizes the exhibitor profile copy.

What we're seeing

• BioPharma Reporter · 2026-06-07
  Cmr Molecular Imaging publishes dosimetry data at SNMMI 2026
  Details remain limited but analysts read the move as a positioning play ahead of pivotal data.
• FierceBiotech · 2026-01-28
  Cmr Molecular Imaging closes Series C round to scale radiopharma manufacturing
  Details remain limited but analysts read the move as a positioning play ahead of pivotal data.
• Endpoints News · 2026-12-21
  Cmr Molecular Imaging partners with academic center on Actinium-225 program
  Coverage notes the company's growing footprint in the radioligand therapy space.
• Reuters Health · 2026-03-14
  Cmr Molecular Imaging files IND for next-generation PSMA-targeted agent
  The work builds on more than a decade of radiochemistry collaboration.
• PR Newswire · 2026-10-23
  Cmr Molecular Imaging announces Phase II readout for lead theranostic candidate
  The work builds on more than a decade of radiochemistry collaboration.

Mocked while we wire the Exa integration. Headlines are illustrative.

What we expect to see at the booth

Booth talking points, demos, and announcements to watch for. Bracken analyst note coming.